TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1)
According to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed in patients with stable ischemic heart disease prior to hospitalization. Significant impro...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/253 |
id |
doaj-360bf3e1ae454d048f9d535be4e1b8e2 |
---|---|
record_format |
Article |
spelling |
doaj-360bf3e1ae454d048f9d535be4e1b8e22021-09-03T13:15:13ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-019213814210.20996/1819-6446-2013-9-2-138-142253TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1)S. N. Tolpygina0Yu. N. Polyanskaya1S. Yu. Martsevich2State Research Centre for Preventive Medicine, MoscowState Research Centre for Preventive Medicine, MoscowState Research Centre for Preventive Medicine, MoscowAccording to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed in patients with stable ischemic heart disease prior to hospitalization. Significant improvement of the treatment quality was found during the cardiology hospital stay. The prescription rate of ACE inhibitors increased from 20% to 84.4%, statins - from 10% to 85.5%, β-blockers - from 20% to 91%, acetylsalicylic acid - from 74% to 96%. However, some drugs (statins) have been used in inadequate doses. Low-density lipoprotein level <2.5 mmol/L was achieved at discharge only in 6.3% of patients.https://www.rpcardio.com/jour/article/view/253ihd register, chronic ischemic heart disease, treatment evaluation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
S. N. Tolpygina Yu. N. Polyanskaya S. Yu. Martsevich |
spellingShingle |
S. N. Tolpygina Yu. N. Polyanskaya S. Yu. Martsevich TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Racionalʹnaâ Farmakoterapiâ v Kardiologii ihd register, chronic ischemic heart disease, treatment evaluation |
author_facet |
S. N. Tolpygina Yu. N. Polyanskaya S. Yu. Martsevich |
author_sort |
S. N. Tolpygina |
title |
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) |
title_short |
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) |
title_full |
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) |
title_fullStr |
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) |
title_full_unstemmed |
TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) |
title_sort |
treatment of patients with chronic ischemic heart disease in real clinical practice according to the data from prognoz ibs register. (part 1) |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-09-01 |
description |
According to the data from PROGNOZ IBS register drugs with proven efficacy in secondary prevention of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed in patients with stable ischemic heart disease prior to hospitalization. Significant improvement of the treatment quality was found during the cardiology hospital stay. The prescription rate of ACE inhibitors increased from 20% to 84.4%, statins - from 10% to 85.5%, β-blockers - from 20% to 91%, acetylsalicylic acid - from 74% to 96%. However, some drugs (statins) have been used in inadequate doses. Low-density lipoprotein level <2.5 mmol/L was achieved at discharge only in 6.3% of patients. |
topic |
ihd register, chronic ischemic heart disease, treatment evaluation |
url |
https://www.rpcardio.com/jour/article/view/253 |
work_keys_str_mv |
AT sntolpygina treatmentofpatientswithchronicischemicheartdiseaseinrealclinicalpracticeaccordingtothedatafromprognozibsregisterpart1 AT yunpolyanskaya treatmentofpatientswithchronicischemicheartdiseaseinrealclinicalpracticeaccordingtothedatafromprognozibsregisterpart1 AT syumartsevich treatmentofpatientswithchronicischemicheartdiseaseinrealclinicalpracticeaccordingtothedatafromprognozibsregisterpart1 |
_version_ |
1717817037767573504 |